FIELD: veterinary pharmaceutics.
SUBSTANCE: invention relates to the use of isoxazoline of structural formula (11‒1) or a salt thereof for the manufacture of a medicinal agent, formulated in the form of a single dose to be administered once a quarter for controlling infestation with fleas and brown dog ixodic tick (Rhipicephalus sanguineus) of dogs and/or cats.
EFFECT: invention provides effective control of infestation of dogs or cats with fleas or ticks.
4 cl, 1 dwg, 9 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS | 2013 |
|
RU2602308C2 |
ISOXAZOLINE COMPOSITIONS AND USE THEREOF AS ANTIPARASITIC AGENTS | 2016 |
|
RU2715051C2 |
ISOXASOLINE COMPOSITIONS AND THEIR APPLICATION AS ANTI-PARASITE MEDICATIONS | 2008 |
|
RU2481837C2 |
ANTIPARASITIC USE OF ISOXAZOLINE COMPOUNDS | 2014 |
|
RU2673723C1 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOXAZOLINE COMPOUNDS | 2013 |
|
RU2646483C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOOXAZOLINE COMPOUNDS | 2013 |
|
RU2772279C2 |
USE OF ISOXAZOLINE COMPOUNDS ON POULTRY | 2014 |
|
RU2688167C1 |
SOFT CHEWING PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2632965C2 |
USE OF ISOXAZOLINE COMPOUNDS IN POULTRY | 2014 |
|
RU2796536C2 |
SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2765231C2 |
Authors
Dates
2024-03-28—Published
2020-02-06—Filed